$54.99
The CP-RET / Cagrilintide Blend combines
5mg of CP-R3 and
5mg of Cagrilintide in a single lyophilized vial,
providing researchers with a convenient dual-peptide formulation for
laboratory investigations into metabolic signaling pathways.
CP-R3 is an investigational triple receptor agonist targeting
the GLP-1, GIP, and glucagon receptors, while Cagrilintide is a
long-acting amylin analogue that acts on amylin receptors associated
with satiety and gastric emptying. Together, these peptides provide
researchers with the opportunity to investigate complementary
mechanisms involved in energy balance, appetite regulation, and
metabolic function.
Combining both peptides into a single vial simplifies laboratory
preparation by reducing the need to reconstitute and handle
multiple individual products while allowing researchers to study
both compounds together in controlled research settings.
This peptide blend is commonly investigated in research involving:
This product is intended strictly for laboratory research purposes
only.
It is not intended for human or veterinary use
and has not been approved by the U.S. Food and
Drug Administration for the diagnosis, treatment, cure, or
prevention of any disease. By purchasing this product, the
purchaser agrees that it will be handled only by qualified
researchers in an appropriate laboratory environment.
Know someone looking for a trusted research supplier?
Share your personal referral link with fellow researchers.
When they place their first qualifying order:
Your reward is automatically issued after their order is completed.
Know someone looking for a trusted research supplier?
Share your personal referral link with fellow researchers.
When they place their first qualifying order:
Your reward is automatically issued after their order is completed.
